4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Myeloid Neoplasm: new trials by email Literature Review of Myeloid Neoplasm trials Research Report on Myeloid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Chlorhexidine Gluconate Skin Cleanser, Laboratory Biomarker Analysis, Mild Soap Skin Cleanser - Bacterial Infection, Benign Neoplasm | Phase 3 | Completed | Children's Oncology Group | 177 | 2013-11-04 | 2021-06-22 |
| Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Asparaginase, Bortezomib, Cytarabine - Acute Myeloid Leukemia, Leukemia Cutis | Phase 3 | Completed | National Cancer Institute (NCI) | 1645 | 2011-07-06 | 2026-06-02 |
| Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Caspofungin Acetate, Fluconazole, Laboratory Biomarker Analysis - Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia | Phase 3 | Completed | Children's Oncology Group | 517 | 2011-04-04 | 2021-03-30 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia Arsenic Trioxide, Cytarabine, Diagnostic Laboratory Biomarker Analysis - Childhood Acute Promyelocytic Leukemia With PML-RARA, Myeloid Neoplasm | Phase 3 | Completed | Children's Oncology Group | 106 | 2009-03-09 | 2022-10-25 |
Leukemia, Myeloid, Acute (2) · Bacterial Infections (1) · Invasive Fungal Infections (1) · Leukemia (1) · Leukemia, Monocytic, Acute (1) · Leukemia, Myelomonocytic, Acute (1) · Mycoses (1) · Neoplasms (1) · Neutropenia (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Sarcoma, Myeloid (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Neoplasms by Histologic Type (3) · Bacterial Infections and Mycoses (2) · Infections (2) · Leukemia (2) · Leukemia, Myeloid (2) · Neoplasms (2) · Agranulocytosis (1) · Cytopenia (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Leukocyte Disorders (1) · Leukopenia (1)
Cytarabine (2) · Mitoxantrone (2) · Arsenic Trioxide (1) · Asparaginase (1) · Bortezomib (1) · Caspofungin (1) · Daunorubicin (1) · Etoposide (1) · Fluconazole (1) · Idarubicin (1) · Leyk (1) · Mercaptopurine (1) · Methotrexate (1) · Sorafenib (1) · Tretinoin (1)
Children's Oncology Group (3) · National Cancer Institute (NCI) (1)
Canada (4) · Puerto Rico (4) · United States (4) · Australia (1) · New Zealand (1)
Danielle M Zerr (1) · John J Gregory (1) · Richard Aplenc (1) · Theoklis E Zaoutis (1)
PMID 28419486, PMID 30773463, PMID 30987448, PMID 31688884, PMID 32029509, PMID 34596937, PMID 34855461, PMID 35349331, PMID 36815378, PMID 37267439, PMID 38295280, PMID 40294366, PMID 42085603
U10CA095861 (2), U10CA098543 (2), UG1CA189955 (2), R01CA163394 (1), U10CA180886 (1)